Literature DB >> 16075661

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications.

Roger S McIntyre1, Jakub Z Konarski, Virginia L Misener, Sidney H Kennedy.   

Abstract

INTRODUCTION: Bipolar disorder (BD) is a highly prevalent and disabling condition with significant mortality risk from suicide and other unnatural causes. This ignominious description is alongside recent observations that the majority of excess deaths in BD are secondary to medical comorbidity. The medical burden in BD is associated with a clustering of risk factors (e.g., obesity, smoking, unhealthy dietary habits) and inadequate utilization of preventative and primary healthcare. Diabetes mellitus (DM) is also a prevalent multifactorial disease which imparts substantial illness burden. Preliminary investigations indicate that patients who suffer from BD with comorbid DM have a more severe course and outcome, lower quality of life, higher prevalence of medical comorbidity and higher cost of illness.
METHODS: We conducted a MedLine search of all English-language articles 1966-2004 using the key words: bipolar disorder, major depressive disorder, diabetes mellitus, glucose metabolism, mortality, overweight, obesity, body mass index. The search was supplemented with manual review of relevant references. Priority was given to randomized controlled data, when unavailable; studies of sufficient sample size are presented.
RESULTS: Subpopulations of BD patients should be considered at high risk for DM. The prevalence of DM in BD may be three times greater than in the general population.
CONCLUSIONS: Bipolar disorder populations may be an at-risk group for glucose metabolic abnormalities. Opportunistic screening and vigilance for clinical presentations suggestive of DM is encouraged.

Entities:  

Mesh:

Year:  2005        PMID: 16075661     DOI: 10.1080/10401230590932380

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  49 in total

Review 1.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

2.  Metabolic adverse events in patients with mental illness treated with antipsychotics: a primary care perspective.

Authors:  Gabriela Balf; Thomas D Stewart; Richard Whitehead; Ross A Baker
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 3.  Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta-analysis.

Authors:  M L Prieto; A B Cuéllar-Barboza; W V Bobo; V L Roger; F Bellivier; M Leboyer; C P West; M A Frye
Journal:  Acta Psychiatr Scand       Date:  2014-05-22       Impact factor: 6.392

4.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

5.  A 12-week weight reduction intervention for overweight individuals taking antipsychotic medications.

Authors:  Carla A Green; Shannon L Janoff; Bobbi Jo H Yarborough; Micah T Yarborough
Journal:  Community Ment Health J       Date:  2014-02-25

Review 6.  The interface of physical and mental health.

Authors:  Anne M Doherty; Fiona Gaughran
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-22       Impact factor: 4.328

7.  An adjunct exercise program for serious mental illness: who chooses to participate and is it feasible?

Authors:  Louisa G Sylvia; Lynne Kopeski; Carrie Brown; Paula Bolton; Corina Laudate; Gina DiGangi; Paula Martin; James A Reid; Jules C Martowski; Amy Meade; Ingrid A Sarmiento; Jianping Wang; Angela C Utschig; Arthur Siegel; Edmund C Neuhaus
Journal:  Community Ment Health J       Date:  2012-10-13

Review 8.  The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline.

Authors:  Andrea Pfennig; Tom Bschor; Peter Falkai; Michael Bauer
Journal:  Dtsch Arztebl Int       Date:  2013-02-08       Impact factor: 5.594

9.  Treating bipolar disorder in the primary care setting: the role of aripiprazole.

Authors:  J Sloan Manning; Susan L McElroy
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 10.  The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

Authors:  Isabella Soreca; Ellen Frank; David J Kupfer
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.